Biotech & Pharma

Google DeepMind and Edison Are Building the AI Scientist

26 sec read8 views0 listens

Google DeepMind and Edison Scientific are developing AI platforms to automate scientific research, aiming to accelerate drug discovery by integrating hypothesis generation, experimental design, and data interpretation. This development is crucial for tech professionals as it promises to significantly reduce the time required for biomedical research, potentially leading to faster breakthroughs in treating diseases like acute myeloid leukemia and liver fibrosis.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Certes Research Warns Legacy Systems Are Biggest Barrier to Quantum Security Readiness

Certes research reveals that legacy systems are the primary barrier to quantum security readiness for most organizations, with 78% of surveyed IT and security leaders citing outdated infrastructure as their biggest risk. This highlights a critical ga...

Ali Nemati

Real Estate & Home1 day ago37 sec read

Study: Bipartisan Social Security plan to borrow and invest unlikely to pay off

A high-profile bipartisan proposal to borrow $1.5 trillion to invest in stocks as a solution to Social Security's projected 2034 shortfall is unlikely to succeed, even under optimistic market conditions, according to new research. For proptech and ho...

Ali Nemati

Tech & Gadgets1 day ago32 sec read

Two AI-based science assistants succeed with drug-retargeting tasks

Google and FutureHouse have introduced two agentic AI systems—Co-Scientist and a separate nonprofit project—designed to assist scientists with tasks like drug retargeting by processing vast amounts of biological data. This matters to developers and r...

Ali Nemati

Cybersecurity1 day ago26 sec read

Mythos Preview Builds PoC Exploits in Automated Vulnerability Research

Anthropic's Mythos Preview, a security-focused AI model, can now chain multiple vulnerabilities into complete, working proof-of-concept exploits. This development significantly accelerates the path from bug discovery to exploitable attack, posing a d...

Ali Nemati

Biotech & Pharma2 days ago25 sec read

Multiple Sclerosis Myelin Loss Revealed by Transcriptomic Analysis in Mice

A new study published in Nature Communications reveals that two mouse models, cuprizone (CPZ) and lysophosphatidylcholine (LPC), offer distinct insights into myelin loss and regeneration relevant to multiple sclerosis research. This comparative analy...

Ali Nemati

Google DeepMind and Edison Are Building the AI Scientist

Related Articles

Certes Research Warns Legacy Systems Are Biggest Barrier to Quantum Security Readiness

Study: Bipartisan Social Security plan to borrow and invest unlikely to pay off

Two AI-based science assistants succeed with drug-retargeting tasks

Mythos Preview Builds PoC Exploits in Automated Vulnerability Research

Multiple Sclerosis Myelin Loss Revealed by Transcriptomic Analysis in Mice